±³½Ç¼Ò°³

    • home
    • ±³½Ç¼Ò°³
    • ±âÃÊÀÇÇÐ

±âÃÊÀÇÇÐ

  • ÀüÀÓ±³¼ö(ÀÇ°ú´ëÇÐ)
  • À̱⿵
  • ȨÆäÀÌÁö ¹Ù·Î°¡±â http://biomed.skku.edu/molimmune
  • Àü°øºÐ¾ß £ü ºÐÀڸ鿪ÇÐ
  • ¿¬¶ôó     £ü (ÀüÈ­) 031-299-6225 / (fax)
  • À̸ÞÀÏ     £ü thylee@skku.edu

ÁÖ¿ä°æ·Â

  • 1993 ÃæºÏ´ëÇб³ ÀÚ¿¬°úÇдëÇÐ, ÀÌÇлç
    1995 ÃæºÏ´ëÇб³ ´ëÇпø ¾àÇаú, ¾àÇм®»ç (¸é¿ªÇÐÀü°ø)
    2002 ¿¬¼¼´ëÇб³ °ø°ú´ëÇÐ »ý¸í°øÇаú, °øÇйڻç (¸é¿ªÇÐÀü°ø)
    1994 - 1998 ¸ñ¾Ï»ý¸í°øÇבּ¸¼Ò, ¿¬±¸¿ø
    2002 - 2003 ¸ñ¾Ï»ý¸í°øÇבּ¸¼Ò, Ã¥ÀÓ¿¬±¸¿ø
    2003 - 2005 Yale University, Section of Immunobiology, Post-doc.
    2005 - 2007 ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ, ÀüÀÓ°­»ç
    2007 - ÇöÀç ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ, ºÐÀÚ¼¼Æ÷»ý¹°Çб³½Ç, Á¶±³¼ö

ÁÖ¿ä°ü½É¿¬±¸

  • 1) Toll-Like Receptor (TLR) ½ÅÈ£Àü´Þ Á¶Àý ´Ü¹éÁú ±âÀü¿¬±¸
    Microbe ȤÀº Virus infectionÀº Innate immune responseÀÇ È°¼ºÀ» À¯µµ ÇÑ´Ù. ÀÌ·¯ÇÑ È°¼ºÀº °¢°¢ÀÇ component¸¦ ƯÀÌÀûÀ¸·Î ÀÎÁöÇÏ´Â TLR¿¡ ÀÇÇØ Á¶ÀýµÇ¸ç, ÇöÀç, ¸¹Àº ¿¬±¸ÀÚµéÀº TLR ½ÅÈ£Àü´ÞÀ» Á¶ÀýÇÏ´Â ¼¼Æ÷³» ´Ü¹éÁúÀÇ ±â´É¿¬±¸¿¡ °üÇÑ ¿¬±¸¸¦ ¼öÇàÇÏ°í ÀÖ´Ù. º» ¿¬±¸½Ç¿¡¼­´Â TLR½ÅÈ£Àü´Þ½Ã ¼¼Æ÷³»ÀÇ I) Peroxiredoxins, II) ASK1, III) AMPK, IV) NOX/LOX ´Ü¹éÁú¿¡ ÀÇÇÑ Á¶Àý±âÀü¿¡ °üÇÑ ¿¬±¸¸¦ ¼öÇàÇÏ°í ÀÖ´Ù.

    2) Toll-Like Receptor¿¡ ÀÇÇÑ NKT¼¼Æ÷ÀÇ È°¼ºÁ¶Àý ±âÀü¿¬±¸
    Innate immune response´Â ´Ù¾çÇÑ Innate immune cellsµé¿¡ ÀÇÇØ Á¶ÀýµÇ¸ç, ÀÌµé ¼¼Æ÷µéÀÇ °ú´ÙÇÑ È°¼ºÀº Áúȯ°ú ¹ÐÁ¢ÇÑ °ü°è¼ºÀÌ ÀÖ´Ù. º» ¿¬±¸½Ç¿¡¼­´Â ƯÁ¤ TLRÀÌ NKT¼¼Æ÷ÀÇ È°¼ºÀ» Á¶ÀýÇÏ¿© Áúȯ ƯÀÌÀû Th1/Th2 dominant ¹ÝÀÀÀ» À¯µµÇÏ´Â ±âÀü¿¡ °üÇÑ ¿¬±¸¸¦ ¼öÇàÇÏ°í ÀÖ´Ù.

    3) Charged MVB protein 5 (CHMP5)ÀÇ ±â´É ¿¬±¸
    CHMP5¶ó´Â ´Ü¹éÁúÀÌ ¸é¿ª¼¼Æ÷ÀÇ ºÐÈ­ ¹× È°¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ °üÇÑ ±âÀü¿¬±¸¸¦ ¼öÇàÇÏ°í ÀÖ´Ù. ÃÖ±Ù ¿¬±¸ÀÚ´Â CHMP5°¡ ¸¶¿ì½ºÀÇ embryogenesis°úÁ¤¿¡¼­ receptor signalingÀÇ down-regulation°ú late endosomeÀÇ ±â´É¿¡ Áß¿äÇÔÀ» ±Ô¸íÇÏ¿´´Ù. À̸¦ ±â¹ÝÀ¸·Î CHMP5°¡ Mature immune¼¼Æ÷ÀÇ È°¼ºÁ¶Àý ¹× Immature T¼¼Æ÷ÀÇ ºÐÈ­¿¡ ¹ÌÄ¡´Â ¿¬±¸¸¦ ¼öÇàÇÏ°í ÀÖ´Ù.

´ëÇ¥¿¬±¸¾÷Àû

  • 1) Eunyoung Chun, Jihyun Lee, Hong Seok Cheong and Ki-Young Lee (2003) Tumor regression by adoptive transferred hepatitis B virus X antigen-specific CD8+ T cells derived from chronic infected patient in xenografted Nude mice. Journal of Immunology, 170:1183-1190.

    2) Eunyoung Chun, Cheol Kyu Han, Jeong Hyeok Yoon, Tae Bo Sim, Yoon-Keun Kim, and Ki-Young Lee. (2005). Novel inhibitors targeted to methionine aminopeptidase (MetAP)-2 strongly Inhibits the growth of cancers in Xenografted nude models. International Journal of Cancer, 114:124-130

    3) Ki-Young Lee, Fulvio D'Acquisto, Matthew S. Hayden, Jae-hyuck Shim and Sankar Ghosh. (2005) PDK1 nucleates T Cell Receptor-Induced signaling complex for NF-kappaB activation. Science, 5718:114-118.

    4) Mihyung Kim, Moon Hee-Bom, Kilhyoun Kim and Ki-Young Lee. (2006) Antigen dose governs the shaping of cytotoxic T lymphocyte repertoires in vitro and in vivo. International Immunology, 18:435-44

    5) Kim TB, Kim SY, Moon KA, Park CS, Jang MK, Yun ES, Cho YS, Moon HB, Lee KY. (2007). Five-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates poly (I:C)-induced airway inflammation in a murine model of asthma. Clin Exp Allergy. 37:1709-19

    6) Moon KA, Kim SY, Kim TB, Yun ES, Park CS, Cho YS, Moon HB, Lee KY. (2007). Allergen-induced CD11b+ CD11cint CCR3+ macrophages in the lung promote eosinophilic airway inflammation in a mouse asthma model. International Immunology. 19:1371-1381

    7) So Yong Kim, Tae Jin Kim, Ki-Young Lee (2008). A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. FEBS letters. 582; 1913-1918

    8) So Yong Kim, Hee-Yeon Jo,Mi Hye Kim, Yun-yi Cha, Sung Won Choi, Jae-Hyuck Shim, Tae Jin Kim, and Ki-Young Lee (2008) H2O2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity. J. Biol. Chem. 283,48; 33563-33568